Phenytoin induced loss of function and delayed dyskinesia

Authors

  • Pablo Díaz Hernández Universidad de Ciencias Médicas de la Habana. Facultad de Ciencias Médicas "General Calixto García". Centro de Investigaciones sobre longevidad, Envejecimiento y Salud, Habana, Cuba. https://orcid.org/0009-0003-6338-9156
  • Liliams Rodríguez Rivera Universidad de Ciencias Médicas de la Habana. Facultad de Ciencias Médicas "General Calixto García". Centro de Investigaciones sobre longevidad, Envejecimiento y Salud, Habana, Cuba. https://orcid.org/0000-0003-1924-2459
  • Daniela Valencia de la Torre Universidad del Valle de México, Estado de Querétaro, México https://orcid.org/0009-0007-5717-7439

Keywords:

adverse drug reaction, loss of function, tardive dyskinesia, phenytoin

Abstract

Introduction: Older adults are particularly vulnerable to adverse drug effects. The consequences of this are an increase in the number and severity of adverse drug reactions, which worsens their health and quality of life, thereby increasing the use of health care resources and the costs of care.

Objective: To describe the complications induced by the use of phenytoin in an elderly woman.

Case Report: 84-year-old female patient with a personal history of hypertension, hypothyroidism, vascular epilepsy treated with phenytoin for 24 years. She was brought for consultation due to loss of function and uncontrolled movements of the limbs and mouth. The patient was found to be dependent for basic and instrumental activities of daily living and in a confusional state. Elevated blood phenytoin concentrations were noted. After drug withdrawal and multidisciplinary interventions, significant functional improvement was achieved.

Conclusions: It should be kept in mind that a patient exposed to phenytoin for a long time may eventually present adverse effects. We must be attentive to this in order to make an early diagnosis of possible complications derived from the use of this drug.

Downloads

Download data is not yet available.

References

1. Belaunde Clausell A, Delgado Prieto J, Bestard Pavón LA. Factores de riesgo para polifarmacia en ancianos hospitalizados. Rev. Gest. Conoc. Desarrollo local. 2025[Citado 15-06-2025]; 12 (1): [aprox. 12 p.]. Disponible en: https://revistas.unah.edu.cu/index.php/RGCDL/article/view/2126.

2. Poblano O, Bautista AC, Acosta O, Gómez PM, Saturno PJ. Polifarmacia en México: un reto para la calidad en la prescripción. Salud Pública Mex. 2020 [Citado 15-06-2025]; 62:859867. Disponible en: https://doi.org/10.21149/11919

3. Ortega López IL, Sagaró Yi NC, Espinosa Ortega Fernández E. Problemas de salud asociados al uso de fármacos en el anciano. Reporte de un caso. I Simposio de salud familiar Gramgi 2021. 2021[Citado 15-06-2025]; ID: 212. Disponible en: https://gramgi2021.sld.cu/index.php/gramgi2021/paper/download/212/513

4. Biagio Santana G, Fernandes Kuriki T, dos Santos Mendes Lemes Soares L. Interações medicamentosas em pacientes psiquiátricos: uma revisão integrativa. Brazilian Journal of Development, Curitiba. 2024[Citado 15-06-2025]; 10(10):01-16. Disponible en: https://ojs.brazilianjournal.com.br/ojs/index.php/BRJD/article/view/73930

5. Belaunde Clausell A, Pacheco Otero Y, Peña Ruiz RM. Síndrome de DRESS asociado al uso de anticonvulsivantes. Revista Cubana de Medicina Militar. 2020[Citado 15-06-2025]; 49(3):e0200461. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/461

6. Marín-Medina DS, Camacho-Gómez OL, Escobedo-Martínez JA, Jaramillo-Toro C, Sánchez-Duque JA. Deprescripción en el anciano con demencia. Acta Neurol Colomb. 2024[Citado 15-06-2025]; 40(2):e1829. Disponible en: https://doi.org/10.22379/anc.v40i2.1829.

7. Barreo Viera L, Bestard Pavón LA, La notificación espontánea de las reacciones adversas a medicamentos. Rev Cub Med Mili. 2022[Citado 15-06-2025]; 51(1): e02201561. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/1561

8. Bolaños Rosales DM, Xajil Ramos LY, González Salazar LS. Medicamentos inductores a reacciones cutáneas severas reportados en países de Iberoamérica. Rev.OFIL.ILAPHAR. 2023[Citado 15-06-2025]; 33(2):174-181. Disponible en. http://scielo,iscii.es/scielo.php?script=sci_arttext&pid=S1699-7142023000200012&Ing=es.

9. Basauri Savelli S, Vásquez V, Maluenda Barrientos F, Hernandez Barbara L. Enfrentamiento inicial de las intoxicaciones por medicamentos orales en el servicio de urgencia. ARS med. (Santiago). 2023 Jun [Citado 15-06-2025]; 48( 2 ): 32-42. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0719-18552023000200032&lng=es.

10. Kashvi Shah C, Nishi Patel S, Paritosh V, Avinash K, Vivek Chavda P, Lalitkumar V. Phenytoin-induced dyskinesia: a case report. Journal of Medical Case Report. 2023[Citado 15-06-2025]; 17:313. Disponible en: https://doi.org/10.1186/s13256-023-04033-6.

Published

2025-07-16

How to Cite

1.
Díaz Hernández P, Rodríguez Rivera L, Valencia de la Torre D. Phenytoin induced loss of function and delayed dyskinesia. GeroInfo [Internet]. 2025 Jul. 16 [cited 2025 Aug. 1];20:e303. Available from: https://revgeroinfo.sld.cu/index.php/gerf/article/view/303

Issue

Section

Presentación de Caso

Most read articles by the same author(s)